PROM1 and glioblastoma: In summary, we successfully tested the biological characteristics of CD133+ and CD133− glioblastoma cells of 8 Han Chinese individuals, verified the high tumorigenicity and invasiveness of CD133+ tumor cells and validated the limitations and deficiencies of the CD133 antigen as a marker to distinguish tumor stem cells.